NDAORALTABLET
Approved
Nov 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 1h ago · AI intelligence enriched 1h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
COMBUNOX is a fixed-dose combination tablet containing ibuprofen (a nonsteroidal anti-inflammatory drug) and oxycodone hydrochloride (an opioid analgesic) approved in 2004. It is indicated for short-term management of acute pain severe enough to require opioid treatment. The combination provides both anti-inflammatory and opioid analgesic activity for moderate-to-severe pain relief.
LOE Approaching
As a product approaching loss of exclusivity with moderate competitive pressure (30/100), the brand team is likely focused on managed decline or transition strategies rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on COMBUNOX offers limited career growth opportunities given its LOE-approaching status and zero linked job openings; roles are primarily focused on managing decline and protecting remaining market share. This product is better suited for mid-career professionals seeking stability or end-of-career portfolio management experience rather than high-growth trajectory roles.
Brand Manager
Worked on COMBUNOX at Forest Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.